Charles Raison, MD

Director of Research

Charles Raison, MD, is a Professor of Human Ecology and Psychiatry in the School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. Dr. Raison also serves as Director of Clinical and Translational Research for Usona Institute and as Director of Research on Spiritual Health for Emory Healthcare in Atlanta, GA. Dr. Raison also serves as Director of the Vail Health Behavioral Health Innovation Center.

The New Mind-Body Science Depression

Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. More recently, Dr. Raison has taken a leadership role in the development of psychedelic medicines as potential treatments for major depression.

The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association “in recognition of his contributions to our understanding of evolutionary biocultural origins of mental health and illness.”

He was named one of the world’s most influential researchers by Web of Science for the decade of 2010-2019. With Vladimir Maletic he is author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017. Dr. Raison serves on the Scientific Advisory Board for the American Foundation for Suicide Prevention.

Learn more about Dr. Raison's work and how it enriches Emory Spiritual Health in this article published in The Journal of Psychedelic Pharmacology. Read it here.

Meet Charles Raison, MD


  • 1976-1980 – Stanford University, Stanford, CA, B.A. in Anthropology with honors and departmental distinction
  • 1982-85 – University of Denver, Denver, CO, M.A. in English, with emphasis in creative writing
  • 1985-86 – Bryn Mawr College, Bryn Mawr, PA, Premedical Program, Post Baccalaureate
  • 1987-91 – Washington University School of Medicine, St. Louis, MO, M.D. degree

Postgraduate Training

  • 1991-1992 – Internship, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute and Hospital, Los Angeles, CA
  • 1992-1995 – Psychiatric Residency, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute and Hospital, Los Angeles, CA
  • 1994-1995 – Chief Resident, Adult Inpatient Services, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute and Hospital, Los Angeles, CA
  • 1984 – Colorado State Fellow, University of Denver, Denver, CO

Bibliography - Scientific Articles Published in Peer-Reviewed Journals:

  1. Raison, C.L., Guze, B.H., Kissell, R.L. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor (letter). Journal of Clinical Psychopharmacology 1994; 14:285-86.
  2. Raison, C.L., Klein, H.M. Psychotic mania associated with fenfluramine and phentermine use (letter). American Journal of Psychiatry 1997; 154: 711.3.
  3. Raison C.L., Klein H.M., Steckler M. The Moon and Madness reconsidered. 1998. Journal of Affective Disorders 53; 1: 99-106.
  4. Raison, C.L., Miller, A.H. The Neuroimmunology of Stress and Depression. Seminars in Clinical Neuropsychiatry. 2001. 6; 4: 277-294.
  5. Raison, C.L., Marcin, M., Miller, A.H. Antidepressant treatment of cytokine-induced depression. Acta Neuropsychiatrica. 2002: 4.
  6. Capuron, L., Raison, C.L., Lawson, D.H., Musselman, D.L., Su, C., Nemeroff, C.B., Miller, A.H. An exaggerated HPA axis response to initial injection of interferon-alpha is associated with depression during interferon-alpha therapy. American Journal of Psychiatry 2003; 160(7): 1342-1345.
  7. Raison, C.L. & Miller, A.H. When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders. American Journal of Psychiatry. 2003; 160: 1554-1565.
  8. Raison, C.L. & Miller, A.H. Depression in Cancer: New Developments Regarding Diagnosis and Treatment. Biological Psychiatry, 2003; 54: 283-294.
  9. Asnis, G.M., De La Garza II, R, Miller, A.H., Raison, C.L., Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects. Journal of Clinical Psychiatry 2004; 65(4): 581.
  10. Raison, C.L., Broadwell, S.D., Borisov, A.S., Manatunga, A.K., Woolwine,B.J., Jacobson, I.M., Nemeroff, C.B., Miller, A.H. Depressive symptoms and viral clearance in patients receiving IFN-alpha and Ribavirin for Hepatitis C. Brain, Behavior and Immunity 2005; 19: 23-27.
  11. Raison, C.L., Borisov, Broadwell, S.D., A.S., Manatunga, A.K., Woolwine, B.J., Jacobson, I.M., Nemeroff, C.B., Miller, A.H. Depression during pegylated IFN-alpha plus ribavirin therapy: prevalence and prediction. Journal of Clinical Psychiatry 2005; 66;1:41-48.
  12. Raison, C.L., Demetrashvili, M., Capuron, L., Miller, A.H. Neuropsychiatric Side Effects of Interferon-alpha: Recognition and Management. CNS Drugs, 2005; 19(2): 1-19.
  13. Raison,C.L., Demetrashvili, M., Capuron L., Miller A.H. The authors' reply. CNS Drugs 2005. 19(8):721-2.
  14. Miller, A.H., Capuron, L., Raison, C.L. Immunologic influences on emotion regulation. Clinical Neuroscience Research 2005; 4(5-6): 235-333.
  15. Yoshida, K., Alagbe, O., Wan, X., Woolwine, B., Thornbury, M., Raison, C.L., Miller, A.H. Promotor polymorphisms of the interferon-alpha receptor gene and development of interferon-induced depressive symptoms in patients with chronic hepatitis C. Neuropsychobiology 2005; 52(2):55-61.
  16. Raison,C,L., Capuron L., Miller A.H. Depressive symptoms and viral clearance: In response. Brain, Behavior, and Immunity 2005; 19(4):273-4.
  17. Raison, C.L., Capuron, L., Miller, A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006. 27(1): 24-31.
  18. Silverman, M.N., Macdougall, M.G., Raison, C.L., Miller, A.H. Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally-infected mice. Molecular Psychiatry 2007; 12(4): 408-17.
  19. Raison, C.L., Woolwine, B.J., Binongo, J., Demitrashvili, M.F., Borisov, A.F., Weinreib, R., Staab, J.P., Zajecka, J.M., Bruno, C.J., Henderson, M.A., Reinus, J.F., Evans, D.L., Asnis, G.M., Miller, A.H. Paroxetine for Prevention of Depressive Symptoms Induced by Interferon-alpha plus Ribavirin for Hepatitis C. Alimentary Pharmacology & Therapeutics 2007; 25(10): 1163-74.
  20. Majer, M., Welberg, L.A., Capuron, L., Pagnoni, G., Raison, C.L., Miller, A.H. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain, Behavior, and Immunity 2008; 22(6): 870-80.
  21. Evans, D., Buxton, D.C., Borisov, A.S., Manatunga, A.K., Ngodup, D., Raison, C.L. (corresponding author). Shattered Shangri-la: differences in depressive and anxiety symptoms in students born in Tibet compared to Tibetan students born in exile. Social Psychiatry and Psychiatric Epidemiology 2008; 43(6): 429-36.
  22. Raison, C.L., Woolwine, B.J., Borisov, A.S., Cowles, Alagbe, O., M.,Vogt, G., Miller, A.H. Effects of Interferon-alpha on diurnal hypothalamic-pituitary-adrenal axis activity and behavior in patients with hepatitis C. Molecular Psychiatry 2010; 15: 535–547.
  23. Raison, C.L., Borisov, A.S., Woolwine, B.J., Vogt, G.J., Massung, B. Miller, A.H. Activation of CNS inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry 2009; 65(4):296-303.
  24. Pace, T.W.W., Negi, L.T., Adame, D, Cole, S.P., Sivilli, T.S., Brown, T., Issa, M., Raison, C.L. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 2009; 34(1):87-98.
  25. Raison, C.L. Lin, J.S., Reeves, W.C. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain, Behavior and Immunity 2009; 23(3):327-37.
  26. Nater, U.M., Lin, J.M., Maloney, E.H., Jones, J.F., Tian, H., Boneva, R.S., Raison, C.L., Reeves, W.C. Psychiatric Comorbidityin Persons with Chronic Fatigue Syndrome Identified from the Georgia Population.Psychosomatic Medicine 2009, Epub.
  27. Miller, A.H., Maletic, V., Raison, C.L. Inflammation and its discontents:the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009; 65(9):732-41.
  28. Maletic, V. & Raison, C.L. At the Crossroads of Mind and Body: Focus on the Neurobiology of Depression, Fibromyalgia and Neuropathic Pain. Frontiers in Bioscience 2009. 14: 5291-5338.
  29. Pace, T.W.W., Negi, L.T., Sivilli, T.S., Issa, M.J., Cole, S.P., Adame, D.D., Raison, C.L. Innate Immune, Neuroendocrine and Behavioral Responses to Psychosocial Stress do not predict Subsequent Compassion Meditation Practice Time. Psychoneuroendocrinology 2010; 35: 310-15.
  30. Raison, C.L., Dantzer, R. Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., Spivey, J.R., Saito, K., Miller, A.H. CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression. Molecular Psychiatry 2010;15: 393-403.
  31. Johnson, T.V., Abbasi, A., Ehrlich, S.S., Kleris, S.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A/ (2010) Major depression drives severity of American Urological Association Symptom Score. Urology 2010. 76(6):1317-1320.
  32. .Nater, U.M., Lin, J.M., Maloney, E.H., Jones, J.F., Tian, H., Boneva, R.S., Raison, C.L., Reeves, W.C. Criteria for chronic fatigue syndrome and co-morbid psychiatric conditions—Response to Kindlon. Psychosomatic Medicine 2009. 71(5):557-65.
  33. Johnson, T.V.,Abbasi, A., Ehrlich, S.S., Kleris, S.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A. Nocturia associated with depressive symptoms. Urology 2011. 77(1):183-6.
  34. Raison, C.L., Rye, D.B., Woolwine, B.J., Vogt, G., Bautista, B.M., Spivey, J., Miller, A.H. Chronic Interferon-Alpha Administration Disrupts Sleep Continuity and Depth in Patients with Hepatitis C: Association with Fatigue, Motor Slowing and Increased Evening Cortisol. Biological Psychiatry 2010;68(10): 942-9.
  35. Johnson, T.V., Abbasi, A., Ehrlich, S.S., Kleris, R.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A. Major depression drives severity of American urological association symptom index. Urology 2010;76(6): 1317-20.
  36. Raison, C.L., Lowry, C.A., Rook, G.A.W. Inflammation, Sanitation and Consternation: Loss of Contact with Co-Evolved, Tolerogenic Micro-Organisms and the Pathophysiology and Treatment of Major Depression, Archives of General Psychiatry 2010 67(12):1211-24.
  37. Rook, G.A.W., Lowry, C.A., Raison, C.L. Lymphocytes in Neuroprotection, Cognition and Emotion: is Intolerance Really the Answer? Brain, Behavior and Immunity 2011; 25(4): 591-601.
  38. Jain, R., Jain, S., Raison, C.L., Maletic, V. Painful Diabetic Neuropathy is more than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators. Current Diabetes Reports 2011; 11(4): 275-84.
  39. Felger, J.C., Alagbe, T., Pace, T.W.W., Woolwine, B.J., Raison, C.L., and Miller AH. Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression.Brain, Behavior and Immunity 2011; 25(6): 1094-8.
  40. Haroon, E., Raison, C.L., Miller, A.H. Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior. Neuropsychopharmacology 2012; 37(1): 137-62.
  41. Raison, C.L. & Miller, A.H. Is Depression an Inflammatory Disorder? Current Psychiatry Reports 2011; 13(6): 467-75.
  42. Felger, J.C., Cole, S.W., Pace, T.W.W., Hu, F., Woolwine, B.J., Doho, G.H., Raison, C.L., Miller, A.H. Molecular Signatures of Peripheral Blood Mononuclear Cells during Chronic Interferon-alpha Treatment: Relationship with Depression and Fatigue. Psychological Medicine 2012; 42: 1591-603.
  43. Raison, C.L. & Miller, A.H. The Evolutionary Significance of Depression in Pathogen Host Defense (PATHOS-D). Molecular Psychiatry 2013; 18::15-37.
  44. Reddy, S.D., Negi, L.T., Dodson-Lavelle, B.,Ozawa de-Silva, B., Pace, T.W., Cole, S.P., Raison, C.L., Craighead, L.W. Cognitively-Based Compassion Training: a promising prevention strategy for at-risk adolescents. Journal of Child and Family Studies 2012; Epub.
  45. Rook, G.A.W., Raison, C.L., Lowry, C.A. Can we vaccinate against depression. Drug Discovery Today 2012; 17: 451-8.
  46. Johnson, T.V., Abbasi, A., Ehrich, S.S., Kleris, R.S., Owen-Smith, A., Raison, C.L. Master, V.A. IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms. Canadian Journal of Urology 2012; 19: 6100-4.
  47. McNutt, M.D., Liu S., Manatunga, A., Royster, E.B., Raison, C.L., Woolwine, B.J., Demetrashvili, M.F., Miller, A.H., Musselman, D.L. Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine. Neuropsychopharmacology 2012; 37:1444-54.
  48. Pace, T.W., Negi, L.T., Dodson-Lavelle, B., Ozawa-de Silva, B. Reddy, S.D., Cole, S.P., Danes, A., Craighead, L.W., Raison, C.L. Engagement with Cognitively-Based Compassion Training is associated with reduced salivary C-reactive protein from before to after training in foster care program adolescents. Psychoneuroendocrinology 2012; 38: 294-9.
  49. Raison, C.L., Haroon, E., Woolwine, B.J., Shuo, C., Haber, M. Rutherford, R., Miller, A.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Archives of General Psychiatry 2012; 70: 31-41.
  50. Mascaro, J.S., Rilling, J.K., Negi, L.T., Raison, C.L. Compassion meditation enhances empathic accuracy and related neural activity. Social Cognitive and Affective Neuroscience 2012; 8: 48-55.
  51. Desbordes, G., Negi, L.T., Pace, T.W., Wallace, B.A., Raison, C.L., Schwartz, E.L. Effects of mindful-attention and compassion meditation training on amygdala response to emotional stimuli in an ordinary, non-meditative state. Frontiers in Neuroscience 2012; 6: 292.
  52. Hale, M.W., Raison, C.L., Lowry, C.A. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Pharmacology & Therapeutics 2012; 137:108-18.
  53. Felger, J.C., Li, L., Marvar, P.J., Woolwine, B.J., Harrison,D.G., Raison, C.L., and Miller, A.H. Tyrosine Metabolism During Interferon-alpha Administration: Association with Fatigue and CSF Dopamine Concentrations.Brain, Behavior, and Immunity 2012; 31:153-60.
  54. Mascaro, J.S., Rilling, J.K., Negi, L.T., Raison, C.L. Pre-existing brain function predicts subsequent practice of mindfulness and compassion meditation. Neuroimage 2013; 69:35-42.
  55. Berg, J.M., Lilienfeld, S.O., Reddy, D., Latzman, R.D., Roose, A., Craighead, L.W., Pace, T.W., Raison, C.L. The Inventory of Callous and Unemotional Traits: A Construct-Validational Analysis in an At-Risk Sample. Assessment 2013; 20: 532-44.
  56. Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C. Cytokine Targets in the Brain: Impact on Neurotransmitters and Neurocircuits. Depression & Anxiety 2013; 30::297-306.
  57. Rook, G.A.W., Lowry, C.A., Raison, C.L. Microbial “Old Friends,” immunoregulation and stress resilience. Evolution, Medicine, and Public Health 2013; 13: 46-64.
  58. Hanusch, K., Janssen, C.H., Billheimer, D, Jenkins, I., Spurgeon, E., Lowry, C.A., Raison, C.L. Whole Body Hyperthermia (WBH) for the Treatment of Major Depression: Associations with Thermoregulatory Cooling. American Journal of Psychiatry 2013; 170: 802-4.
  59. Mehta, D., Raison, C.L., Woolwine, B.J., Haroon, E., Binder, E.B., Miller, A.H., Felger, J.C. Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain, Behavior and Immunity 2012;31:205-15.
  60. Rook, G.A., Raison, C.L., Lowry, C.A. Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries. Evolution, Medicine, and Public Health 2013; 12: 14-17.
  61. Rook, G.A.W., Raison, C.L., Lowry, C.A. Microbial “Old Friends,” immunoregulation and socio-economic status. Clinical and Experimental Immunology 2014; 177: 1-12.
  62. Whisman, M.A., Li, A., Sbarra, D.A., Raison, C.L. Marital quality and diabetes: results from the health and retirement study. Health Psychology 2014; 33: 832-40.
  63. Rook, G.A., Raison, C.L., Lowry, C.A. Microbiota, immunoregulatory old friends and psychiatric disorders. Advances in Experimental Medical Biology 2014; 817: 319-56.
  64. Raison C.L. Inflammatory depression: a trifecta of trouble. Journal of Clinical Psychiatry 2014; 75: 663-4.
  65. Rook, G.A., Lowry, C.A., Raison, C.L. Hygiene and other early childhood influences on the subsequent function of the immune system. Brain Research 2014; S0006-8993(14)00481-8.
  66. Maletic V & Raison, C.L. Integrated neurobiology of bipolar disorder. Frontiers in Psychiatry 2014; 5:98
  67. Weinberger, J.F., Raison, C.L., Montague, A.K., Woolwine, B.J., Felger, J.C., Haroon, E. Miller, A.H.Inhibition of Tumor Necrosis Factor Improves Sleep Continuity in Patients with Treatment Resistant Depression and High Inflammation. Brain, Behavior and Immunity 2014: 47: 193-200.
  68. Raison, C.L., Hale, M.W., Williams, L.E., Wager, T.D., Lowry, C.A. Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. Frontiers in Psychology, Section Cognition 2015; Jan 13; 5: 1580
  69. Maletic V& Raison C. The integrated neurobiology of bipolar disorder. Frontiers in Psychiatry 2014;5:98. doi: 10.3389/fpsyt.2014.00098.
  70. Miller, A.H. & Raison, C.L. Where the Rubber Meets the Road: Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders? JAMA Psychiatry 2015; 72: 527-8.
  71. Mascaro,J.S., Darcher, A., Negi, L.T. Raison, C.L. The neural mediators of kindness-based meditation: a theoretical model.Frontiers in Psychology, Section Cognition2015; 12: 109.
  72. Pruimboom, L., Raison, C.L., Muskiet, F.A.J.Physical activity protects the human brain against metabolic stress induced by a postprandial and chronic inflammation. Behavioural Neurology 2015; 2015:569869
  73. Dodds,S.E., Pace, T.W.W., Bell, M.L., Fiero, M., Negi, L.T., Raison, C.L, and Weihs, K. Feasibility of Cognitively-Based Compassion Training(CBCT) for Breast Cancer Survivors: A Randomized, Wait List Controlled Pilot Study. Supportive Care in Cancer 2015; 23: 3599-608.
  74. Miller, A.H. & Raison, C.L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16: 22-34.
  75. Felger, J.C., Haroon, E., Woolwine, B.J., Raison, C.L., and Miller, A.H. 2016. Interferon-alpha-Induced Inflammation is Associated with Reduced Glucocorticoid Negative Feedback Sensitivity and Depression in Patients with Hepatitis C Virus. Physiology & Behavior 2016; 166:14-21
  76. Bollich, K.L., Doris, J.M., Vazire, S, Raison, C.L., Jackson, J.J. Mehl, M.R. Eavesdropping on Character: Assessing Everyday Moral Behaviors. Journal of Personality Research 2016; 61:15-21
  77. Janssen, C.W. Lowry, C.A., Mehl, M.R., Allen, J.J.B., Kelly, K.L., Gartner, D.E., Medrano, A., Begay, T.K., Rentscher, K., White, J.J., Fridman, A., Roberts, L.J., Robbins, M.L., Hanusch, K. Cole, S.P., Raison, C.L. Whole body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2016; 73: 780-95
  78. Raison, C.L. The promise and limitations of anti-inflammatory agents for the treatment of major depressive disorder. Current Topics in Behavior Neurosciences 2016; epub
  79. Pruimboom, L., Ruiz-Nunez, B., Raison, C.L., Muskiet, F.A.J. Influence of 10 days mimic of our ancient lifestyle on anthropometrics and parameters of metabolism and inflammation. JBiomedical Research International 2016;2016:6935123
  80. Lowry, C.A., Smith, D.G., Siebler, P.H., Schmidt, D., Stamper, C.E., Hassell, J.E. Jr., Yamashita, P.S., Fox, H.H., Reber, S.O., Brenner, L.A., Hoisington, A.J., Postloche, T.T., Kinney, K.A., Marciani, D., Hernandex, M., Hemmings, S.M., Malan-Muller, S., Wrigth, K.P., Knight, R., Raison, C.L., Rook, G.A. The microbiota, immunoregulation, and mental health: implications for public health. Current Environmental Health Reports 2016;3(3):270-86
  81. Raison, C.L., Lowry, C.A., Janssen, C.W. Hyperthermia for major depression?—reply. JAMA Psychiatry 2016;73(10):1096-1097
  82. Reber, S.O., Siebler, P.H., Donner, N.C., Morton, J.T., Smith, D.G., Kopelman, J.M., Lowe, K.R., Wheeler, K.J., Fox, J.H., Hassell, J.E. Jr., Greenwood, B.N., Jansch, C., Lechner, A., Schmidt, D., Uschold-Schmidt, N., Füchsl, A.M., Langgartner, D., Walker, F.R., Hale, M.W., Lopez Perez, G., Van Treuren, W., González, A., Halweg-Edwards, A.L., Fleshner, M.,Raison,C.L., Rook, G.A., Peddada, S.D.,Knight,R.,Lowry,C.A.Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. Proc Natl Acad Sci U S A 2016;113(22):E3130-9.
  83. Raison, C.L. &Miller, A.H. Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology 2017; 42(1): 5-27
  84. Reed, R.G., O’Connor, M-F. Pace, T.W.W., Raison, C.L., Butler, E.A. Dyadic coping and salivary interleukin-6 responses to interpersonal stress. Journal of Family Psychology; Epub
  85. Mascaro, J.S., Kelley, S., Darcher, A., Negi, L.T., Worthman, C., Miller, A.H., Raison, C.L. Meditation buffers medical student compassion from the deleterious effects of depression. Journal of Positive Psychology 2016; Epub
  86. Kohler, C.A., Freitas, T.H., Maes, M., de Andrade, N.Q., Liu, C.S., Fernandes, B.S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., Raison, C.L., Miller, B.J., Lanctot, K.L., Carvalho, A.F.Peripheral cytokine and chemokine alterations in depression: an up-dated meta-analysis of 82 studies. Acta Psychiatrica Scandinavia 2017; 135(5):373-387
  87. Kohler, C.A., Freitas, T.H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., Andrede, N.Q., Morris, G., Fernandes, B.S., Brunoni, A.R., Hermann, N., Raison, C.L., Miller, B.J., Lactot, K.L., Carvalho, A.Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment: systematic review and meta-analysis. Molecular Neurobiology 2017; Epub.
  88. Hale, M.W., Lukkes, J.L., Dady, K.F., Kelly, K.J., Paul, E.D., Smith, D.G.,Raison, C.L., Lowry, C.A. Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats. Progress in Neuropsychopharmacology and Biological Psychiatry 2017; 79(Pt B): 162-8
  89. Mehl, M., Raison, C.L., Pace T., Cole, S.W. Natural language indicators of differential gene regulation in the human immune system. Proceedings of the Natl Acad Sci U S A 2017; 114(47):12554-59
  90. Raison, C.L. & Raichlen, D.A. An evolutionary perspective on nutrition and social decision making. Proc Natl Acad Sci U S A2018; Epub
  91. Quinn, A.M., Williams, A.R., Sivilli, T.I., Raison, C.L., and Pace, T.W.W. The plasma interleukin-6 response to acute psychosocial stress in humans is detected by a magnetic multiplex assay: Comparison to high-sensitivity ELISA. Stress 2018; epub
  92. Milek, A., Butler, E. A., Tackman, A. M., Kaplan, D. M., Raison, C. L., Sbarra, D. A., Vazire, S., & Mehl, M. R. (in press). “Eavesdropping on happiness” revisited: A pooled, multi-sample replication of the association between life satisfaction and observed daily conversation quantity and quality. Psychological Science 2018; Epub
  93. Raison, C.L., Pikalov, A., Siu, C., Tsai J, Koblan, K., Loebe,l A. C-reactive protein and response to lurasidone in patients with bipolar depression.Brain Behav Immun 2018;73:717-724
  94. Hale, M.W., Lukkes, J.L., Dady, K.F., Kelly, K.J., Paul, E.D., Smith, D.G., Heinze, J.D.,Raison, C.L., Lowry, C.A. Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats. Behavior Brain Research 2018; epub
  95. Kaplan, D.M., Raison, C.L., Milek, A., Tackman, A.M., Pace, T.W.W., Mehl, M.R. Dispositional mindfulness in daily life: naturalistic observation study. PLoS One 2018; epub.
  96. Poehlmann-Tynan, J., Engbretson, A., Vigna, A.B., Weymouth ,LA, Burnson, C., Zahn-Waxler, C., Kapoor, A., Gerstein, E.D., Fanning, K.A., Raison, C.L. Cognitively-Based Compassion Training for parents reduces cortisol in infants and young children. Infant Mental Health Journal 2019; Epub
  97. Raison, C.L., Siu, C., Pikalov, A., Tocco, M., Loebel, A. C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial. Brain, Behavior and Immunity 2019, Epub
  98. Goldberg, S. B., Pace, B. T., Nicholas, C. R., Raison, C. L., & Hutson, P. R. (in press). The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis. Psychiatry Research 2020; Epub
  99. Perez, M., Raison, C.L., Coe, C.,Cook, D., Meyer, J. Cytokine responses across submaximal exercise intensities in women with major depressive disorder. Brain, Behavior, and Immunity –Health2020; Epub

Honors & Awards:

  • 2019 – Named one of the world’s most influential researchers of the decade
  • 2010-2019 – by Web of Science based on article citations
  • 2019 – Simson Lecture, Annual Institute for Behavioral Medicine Research (IBMR) Research Day, Ohio State University, Columbus, OH
  • 2018 – William K. Warren Memorial Lecture, Laureate Institute for Brain Research, Tulsa, OK
  • 2018 – Eli Robbins Memorial Lecture, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO
  • 2016 – Xiaohong Wang Memorial Lecture, Department of Psychiatry, Emory University
  • 2015 – Named one of five university-wide “Faculty of Excellence” highlighted for the launch of the “All Ways Forward” Capital Campaign, University of Wisconsin-Madison
  • 2015 – James L. Stinnett Honorary Lecture, Department of Psychiatry, University of Pennsylvania
  • 2014 – Raymond Pearl Award for “contributions to our understanding of evolutionary biocultural origins of mental health and illness,” Human Biology Association
  • 2014 – Principal Guest Scientist, 31stMidwest Symposium on Family Systems Theory and Therapy
  • 2014 – Invited to give Bench-to-Bedside Keynote Address at the International Behavioral Neuroscience Society (IBNS) meeting
  • 2013 – NARSAD Independent Investigator Award (Brain & Behavior Research Society)
  • 2012 – Chairman of the U.S. Psychiatric and Mental Health Congress
  • 2011 – Champion of Hope Award from the Africa’s Children’s Fund
  • 2011 – Distinguished Visiting Professorship, Brooke Army Medical Center, San Antonio, TX
  • 2011 – Chairman of the U.S. Psychiatric and Mental Health Congress
  • 2008 – Semi-finalist presidential search for Naropa University, Boulder, CO
  • 2006 – Emory College Seed Fund Award to Improve the Research Profile of the Arts and Sciences
  • 2005 – Emory College Seed Fund Award to Improve the Research Profile of the Arts and Sciences
  • 2005 – Emory University Teaching Fund Award to develop interdisciplinary course entitled Phenomenology of Depression: Body, Mind and Culture.
  • 2003 – Emory University Medical Students’ Teaching Award for Psychiatry
  • 2002 – National Institutes of Health Extramural Loan Repayment Program Award
  • 2001 – Bristol Meyers Squibb Young Faculty Development Award
  • 2001 – Emory University Psychiatry Senior Residents’ Outstanding Educator Award
  • 2000 – Emory University Teaching Fund Award for the development of an interdisciplinary course entitled Psychobiological Foundations of Personhood: Tibetan Buddhist and Western Perspectives
  • 1993 – American Psychoanalytic Association Fellow
  • 1991 – Alpha Omega Alpha, Washington University Chapter
  • 1991 – Missouri State Medical Association Award

Return to Leadership Page

Return to Staff Page